Raymond J. Bergeron

7.4k total citations
186 papers, 6.5k citations indexed

About

Raymond J. Bergeron is a scholar working on Molecular Biology, Biochemistry and Organic Chemistry. According to data from OpenAlex, Raymond J. Bergeron has authored 186 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Molecular Biology, 50 papers in Biochemistry and 42 papers in Organic Chemistry. Recurrent topics in Raymond J. Bergeron's work include Polyamine Metabolism and Applications (69 papers), Amino Acid Enzymes and Metabolism (48 papers) and Iron Metabolism and Disorders (30 papers). Raymond J. Bergeron is often cited by papers focused on Polyamine Metabolism and Applications (69 papers), Amino Acid Enzymes and Metabolism (48 papers) and Iron Metabolism and Disorders (30 papers). Raymond J. Bergeron collaborates with scholars based in United States, France and Australia. Raymond J. Bergeron's co-authors include Carl W. Porter, James S. McManis, Jan Wiegand, William R. Weimar, Paul R. Libby, Michael A. Channing, Gary M. Brittenham, B. Ganis, Robert A. Casero and J. R. Timothy Vinson and has published in prestigious journals such as Science, Chemical Reviews and Journal of the American Chemical Society.

In The Last Decade

Raymond J. Bergeron

186 papers receiving 6.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raymond J. Bergeron United States 48 4.2k 2.0k 1.3k 1.3k 657 186 6.5k
Robert H. Abeles United States 57 6.3k 1.5× 1.4k 0.7× 1.7k 1.3× 406 0.3× 142 0.2× 191 9.4k
Richard N. Armstrong United States 45 5.7k 1.3× 833 0.4× 594 0.5× 283 0.2× 188 0.3× 142 7.4k
Juan C. Fontecilla‐Camps France 60 3.9k 0.9× 244 0.1× 929 0.7× 879 0.7× 439 0.7× 153 14.1k
William C. Stallings United States 27 1.8k 0.4× 374 0.2× 1.6k 1.2× 1.5k 1.1× 121 0.2× 66 5.1k
Michael E. Jung United States 55 4.7k 1.1× 567 0.3× 7.6k 5.8× 988 0.8× 145 0.2× 377 13.6k
Hideko Nagasawa Japan 44 2.4k 0.6× 169 0.1× 1.8k 1.4× 289 0.2× 308 0.5× 195 6.7k
Carsten Krebs United States 68 7.0k 1.7× 489 0.2× 1.5k 1.2× 493 0.4× 453 0.7× 205 14.2k
R. Heiner Schirmer Germany 49 4.3k 1.0× 1.3k 0.7× 1.1k 0.9× 268 0.2× 40 0.1× 104 7.6k
F.M. Huennekens United States 44 3.8k 0.9× 537 0.3× 506 0.4× 97 0.1× 315 0.5× 173 6.2k
Raymond L. Blakley United States 46 4.4k 1.0× 455 0.2× 553 0.4× 79 0.1× 390 0.6× 161 6.4k

Countries citing papers authored by Raymond J. Bergeron

Since Specialization
Citations

This map shows the geographic impact of Raymond J. Bergeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond J. Bergeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond J. Bergeron more than expected).

Fields of papers citing papers by Raymond J. Bergeron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond J. Bergeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond J. Bergeron. The network helps show where Raymond J. Bergeron may publish in the future.

Co-authorship network of co-authors of Raymond J. Bergeron

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond J. Bergeron. A scholar is included among the top collaborators of Raymond J. Bergeron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond J. Bergeron. Raymond J. Bergeron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guillemot, Gildas, et al.. (2024). Mesoscale multilayer multitrack modeling of melt pool physics in laser powder bed fusion of lattice metal features. Additive manufacturing. 93. 104365–104365. 2 indexed citations
2.
Kramer, Debora L., Jennifer D. Black, Helmut Mett, Raymond J. Bergeron, & Carl W. Porter. (1998). Lysosomal sequestration of polyamine analogues in Chinese hamster ovary cells resistant to the S-adenosylmethionine decarboxylase inhibitor, CGP-48664.. PubMed. 58(17). 3883–90. 11 indexed citations
3.
Kramer, Debora L., Mirjana Fogel‐Petrovic, Paula Diegelman, et al.. (1997). Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells.. PubMed. 57(24). 5521–7. 47 indexed citations
4.
Bergeron, Raymond J., Jan Wiegand, Charles A. Sninsky, & Michael J. Katovich. (1995). The Impact of Polyamine Analogues on the Blood Pressure of Normotensive and Hypertensive Rats. Clinical and Experimental Hypertension. 17(8). 1197–1217. 4 indexed citations
5.
Bergeron, Raymond J., et al.. (1994). An Investigation of Desferrithiocin Metabolism. Journal of Medicinal Chemistry. 37(18). 2889–2895. 9 indexed citations
6.
Davidson, Nancy E., et al.. (1993). Growth inhibition of hormone-responsive and -resistant human breast cancer cells in culture by N1, N12-bis(ethyl)spermine.. PubMed. 53(9). 2071–5. 55 indexed citations
7.
Porter, Carl W., Ralph J. Bernacki, John Miller, & Raymond J. Bergeron. (1993). Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.. PubMed. 53(3). 581–6. 67 indexed citations
8.
Casero, Robert A., et al.. (1992). Steady-state messenger RNA and activity correlates with sensitivity to N1,N12-bis(ethyl)spermine in human cell lines representing the major forms of lung cancer.. PubMed. 52(19). 5359–63. 76 indexed citations
9.
Shappell, Nancy W., John T. Miller, Raymond J. Bergeron, & Carl W. Porter. (1992). Differential effects of the spermine analog, N1, N12-bis(ethyl)-spermine, on polyamine metabolism and cell growth in human melanoma cell lines and melanocytes.. PubMed. 12(4). 1083–9. 47 indexed citations
10.
Bernacki, Ralph J., Raymond J. Bergeron, & Carl W. Porter. (1992). Antitumor activity of N,N'-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts.. PubMed. 52(9). 2424–30. 85 indexed citations
11.
Porter, Carl W., B. Ganis, Paul R. Libby, & Raymond J. Bergeron. (1991). Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines.. PubMed. 51(14). 3715–20. 184 indexed citations
12.
Bergeron, Raymond J., et al.. (1991). The total synthesis of alcaligin. The Journal of Organic Chemistry. 56(19). 5560–5563. 29 indexed citations
13.
Bergeron, Raymond J., Richard R. Streiff, Jan Wiegand, et al.. (1990). A Comparative Evaluation of Iron Clearance Models. Annals of the New York Academy of Sciences. 612(1). 378–393. 51 indexed citations
14.
Casero, Robert A., et al.. (1990). Differential induction of spermidine/spermine N1-acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues. Lung Cancer. 6(1-2). 48–48. 147 indexed citations
15.
Libby, Paul R., M J Henderson, Raymond J. Bergeron, & Carl W. Porter. (1989). Major increases in spermidine/spermine-N1-acetyltransferase activity by spermine analogues and their relationship to polyamine depletion and growth inhibition in L1210 cells.. PubMed. 49(22). 6226–31. 50 indexed citations
16.
Taetle, Raymond, et al.. (1989). Combination Iron Depletion Therapy. JNCI Journal of the National Cancer Institute. 81(16). 1229–1235. 33 indexed citations
17.
Bergeron, Raymond J., et al.. (1988). Synthetic polyamine analogs as antineoplastics. Journal of Medicinal Chemistry. 31(6). 1183–1190. 169 indexed citations
18.
Porter, Carl W., F G Berger, Anthony E. Pegg, B. Ganis, & Raymond J. Bergeron. (1987). Regulation of ornithine decarboxylase activity by spermidine and the spermidine analogue N1N8-bis(ethyl)spermidine. Biochemical Journal. 242(2). 433–440. 47 indexed citations
19.
Bergeron, Raymond J., et al.. (1987). Synthesis of a parabactin photoaffinity label. The Journal of Organic Chemistry. 52(1). 144–149. 9 indexed citations
20.
Bergeron, Raymond J., et al.. (1984). Antineoplastic and antiherpetic activity of spermidine catecholamide iron chelators. Biochemical and Biophysical Research Communications. 121(3). 848–854. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026